Blockade of cannabinoid CB1 receptors potentiates the anti‐fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy.

Saved in:
Bibliographic Details
Title: Blockade of cannabinoid CB1 receptors potentiates the anti‐fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy.
Authors: Pointeau, Océane1 (AUTHOR), Ba, Awa Isma1 (AUTHOR), Geissler, Audrey1,2 (AUTHOR), Barbosa, Romain1 (AUTHOR), Basu, Abhishek3 (AUTHOR), Muhammad, Arif3,4 (AUTHOR), Nivot, Marina1 (AUTHOR), Loriot, Maéva1 (AUTHOR), Leemput, Julia1 (AUTHOR), Passilly‐Degrace, Patricia1 (AUTHOR), Causse, Sébastien1 (AUTHOR), Demizieux, Laurent1 (AUTHOR), François, Hélène5,6 (AUTHOR), Vergès, Bruno1 (AUTHOR), Duan, Jianmin7 (AUTHOR), Gaucher, Geneviève7 (AUTHOR), Harvey, Michael7 (AUTHOR), Degrace, Pascal1 (AUTHOR), Crater, Glenn7 (AUTHOR), Cinar, Resat3 (AUTHOR)
Source: British Journal of Pharmacology. Nov2025, Vol. 182 Issue 21, p5355-5377. 23p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00071188
DOI:10.1111/bph.70118